RxDoctor Payments DataLook up a doctor →

Tasha Boone, MD

Family Medicine · Irmo, SCNPI 1699745141

Payments from drug & device makers

$1,880,893in general payments, 2019–2025

Across 1,045 payments — averaging $1799.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$1.1M
  • GSK$148K
  • AbbVie$114K
  • Astellas Pharma Global Development$91K
  • Cue Health Inc.$87K
  • AstraZeneca$82K
  • plus $215K from 54 others
$2,411in research payments, 2019–2025

Across 5 payments — averaging $482.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.65$1,145,219
GSK83$147,908
AbbVie(2 entities)165$114,283
Astellas Pharma Global Development48$90,551
Cue Health Inc.3$86,740
AstraZeneca73$81,658
Sumitomo Pharma America, Inc.15$65,873
Novo Nordisk AS6$48,123
Eli Lilly9$47,767
Chiesi USA, Inc.5$17,977
Pfizer19$12,593
Takeda Pharmaceuticals U.S.A., Inc.16$8,736
Akebia Therapeutics Inc8$4,043
Novo Nordisk59$1,077
Boehringer Ingelheim50$1,015
Lilly USA, LLC62$979
Otsuka America Pharmaceutical, Inc.31$643
Sanofi-aventis U.S. LLC36$643
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC46$635
Forte Bio-pharma LLC7$477
Amgen26$462
Teva Pharmaceuticals USA, Inc.46$459
Merck21$307
Axsome Therapeutics, Inc.10$247
Abbott13$236
Bayer10$185
Astellas Pharma US Inc9$176
Amarin Pharma, Inc.10$148
Novartis9$145
Edwards Lifesciences5$129
Baxter Healthcare1$116
Biohaven Pharmaceutical Holding Company Ltd.7$115
Exact Sciences6$94
Xeris Pharmaceuticals, Inc.5$92
Eisai Inc.6$89
Dexcom, Inc.3$81
Arbor Pharmaceuticals, Inc.5$79
Ironwood Pharmaceuticals, Inc4$72
Esperion Therapeutics, Inc.4$67
Daiichi Sankyo Inc.3$64
Shire North American Group Inc4$62
Idorsia Pharmaceuticals US Inc4$59
Phathom Pharmaceuticals, Inc.3$56
Cashflow Solutions, LLC3$42
Avadel CNS Pharmaceuticals, LLC2$40
Harmony Biosciences LLC2$34
Genentech USA, Inc.2$31
E.r. Squibb & Sons, L.L.C.2$29
Mannkind Corporation2$29
Jazz Pharmaceuticals Inc.1$29
Currax Pharmaceuticals LLC2$23
Boston Scientific1$22
Stryker1$22
Ardelyx, Inc.1$21
Lundbeck LLC1$20
Johnson & Johnson1$18
Corcept Therapeutics1$15
Philips North America LLC1$15
Ironshore Pharmaceuticals Inc.1$12
Biohaven Pharmaceuticals, Inc.1$12

How this compares

$1,880,893 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina →

Medicare billing

Part B allowed, 2024
$98,359
Medicare patients
181
Services billed
1,531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Irmo

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →